Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2021 · Nature Medicine · 270 citations
https://doi.org/10.1038/s41591-021-01488-2
S
Sylvia Torrance
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
2.0K
Citations
14
h-index
16
i10-index
Sylvia Torrance is an academic researcher from Canadian Blood Services. The author has contributed to research in topics: Organ Donation and Transplantation & Palliative Care and End-of-Life Issues & Cerebrospinal fluid and hydrocephalus. The author has an h-index of 14, co-authored 19 publications.
ORCID: 0000-0003-2231-5866Papers by this author
worksInternational guideline development for the determination of death
2014 · Intensive Care Medicine · 263 citations
https://doi.org/10.1007/s00134-014-3242-7
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
2021 · JAMA · 209 citations
https://doi.org/10.1001/jama.2021.18178
A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline
2023 · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 120 citations
https://doi.org/10.1007/s12630-023-02431-4
Heart donation and transplantation after circulatory determination of death: expert guidance from a Canadian consensus building process
2021 · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 31 citations
https://doi.org/10.1007/s12630-021-01926-2
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
2022 · Nature Medicine · 3 citations
https://doi.org/10.1038/s41591-021-01667-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat